Catalyst Funds Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$831K Buy
3,500
+999
+40% +$208K 0.05% 321
2026
Q1
$528K Buy
2,501
+1,001
+67% +$216K 0.09% 237
2025
Q4
$308K Buy
+1,500
New +$282K 0.07% 226
2024
Q4
Sell
-600
Closed -$66.3K 465
2024
Q3
$66.3K Buy
+600
New +$62.7K 0.01% 662
2024
Q2
Sell
-3,800
Closed -$425K 1224
2024
Q1
$425K Buy
+3,800
New +$410K 0.12% 150

Other funds holding CAH

Catalyst Funds Management's CAH Position: Q2 2026 in Review

Catalyst Funds Management increased its Cardinal Health (CAH) stake by 40% in Q2 2026, buying an estimated $208K and bringing the position to 3,500 shares worth $831K. The position accounts for 0.05% of the portfolio, ranked #321.

Catalyst Funds Management first reported a position in CAH in Q1 2024 and has held it in 5 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Catalyst Funds Management held 3,500 shares of Cardinal Health worth $831K as of Q2 2026.
  • Catalyst Funds Management bought 999 Cardinal Health shares in Q2 2026, an estimated $208K.
  • Cardinal Health made up 0.05% of Catalyst Funds Management's portfolio in Q2 2026, its #321 holding.
  • Catalyst Funds Management first reported a position in Cardinal Health in Q1 2024 and has held it in 5 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.